Every 424B that Bluerock Homes Trust, Inc. (BHM) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BHM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BHM filings page.
Bluerock Homes Trust, Inc. updates its Form S-11 prospectus to incorporate multiple recent reports, primarily detailing dispositions of single-family rental homes from two joint-venture portfolios and related pro forma financials, governance actions, and an external management agreement amendment.
The company sold 35 Golden Pacific units for an aggregate ~$9.0 million (net proceeds ~$8.1 million) and later an additional 26 Golden Pacific units for ~$7.2 million (net proceeds ~$6.4 million). It also sold 24 Ballast units for ~$8.5 million (net proceeds ~$7.8 million) and a further 21 Ballast units for ~$7.1 million (net proceeds ~$6.4 million). Unaudited pro forma condensed consolidated statements show the impact of these sales on revenues, expenses and net loss, based on assumptions management considers reasonable.
The filing also reports the June 10, 2026 annual meeting results, where five directors were elected and Grant Thornton LLP was ratified as independent auditor, and a Third Amendment to the Management Agreement that clarifies an “Investment Transaction” includes a “Financing Transaction” for purposes of the company’s investment guidelines.
Bluerock Homes Trust, Inc. files a Prospectus Supplement to its Registration Statement on Form S-11 to update the Prospectus with information included in its Form 10-Q filed May 7, 2026.
The supplement incorporates the Company’s Q1 2026 unaudited financial results, including total assets $1,142,945 (in thousands) and a net loss $10,297 (in thousands) for the three months ended March 31, 2026. The supplement is qualified by reference to the Prospectus and is effective only with the Prospectus.
Bluerock Homes Trust, Inc. is offering up to 14,000,000 shares of Series B Redeemable Preferred Stock at $25.00 per share. The prospectus states the Series B pays cumulative dividends at an annual rate of 7.5%, will be non‑traded and rank senior to the common stock. The issuer estimates net proceeds of approximately $310.63 million from a full primary offering and discloses selling commissions and placement fees that can total up to 10.0% of gross proceeds (FINRA cap). Shares are redeemable at the holder’s option at a $25.00 stated value less a declining redemption fee (12% initially down to 0% after four years); redemptions may be paid in cash or in Class A common stock. The offering is continuous through December 10, 2027 (extendable to December 10, 2028) at the company’s discretion.
Bluerock Homes Trust, Inc. filed a Prospectus Supplement that updates its registration statement and supplements the Prospectus with its Annual Report on February 27, 2026. The supplement incorporates the Form 10-K and should be read together with the Prospectus.
As disclosed in the attached Form 10-K, as of December 31, 2025 the company held 25 real estate investments totaling an aggregate of 5,572 residential units, including 4,423 consolidated units (with 370 units under development or lease-up). Consolidated operating investments were approximately 90.9% occupied (93.0% excluding held-for-sale and down/renovation units). The Form 10-K also describes the company’s REIT status, distribution policies for Series A and B preferred stock, and material risk factors.
Bluerock Homes Trust, Inc. files a Prospectus Supplement No. 4 that updates its registration statement by attaching its Annual Report on Form 10-K filed with the SEC on February 27, 2026.
The supplement amends the Prospectus dated April 9, 2025 (and prior supplements) and directs readers to the Risk Factors and Management’s Discussion and Analysis contained in the attached Form 10-K. The 10-K discloses that shares outstanding were 4,047,114 Class A and 8,489 Class C as of February 20, 2026, and reports an aggregate market value of Class A common stock held by non-affiliates of $50,839,325 as of June 30, 2025. The supplement is qualified by reference to the Prospectus and reiterates that investing involves significant risks described in the Prospectus and the attached 10-K.